A previous report claimed no evidence of transgenerational epigenetic inheritance in a mouse model of in utero environmental exposure, based on the observation that gene expression changes observed in the germ cells of G1 and G2 male fetus were not in the same direction. A subsequent data reanalysis however showed a statistically significant overlap between G1 and G2 genes irrespective of direction, leading to the suggestion that, as phenotypic variability in epigenetic transmission has been observed in several other examples also, the above report provided evidence in favor of, not against, transgenerational inheritance. This criticism has recently been questioned. Here, it is shown that the questions raised are based not only on incorrect statistical calculations but also on wrong premise that gene expression changes do not constitute a phenotype.
Introduction
Iqbal et al. [1] previously claimed, based mainly on gene expression data, that endocrine disrupting chemicals (EDCs) do not cause transgenerational effects in mammals. In brief, the authors treated G0 female mice with the EDCs vinclozolin (VZ), and di-(2-ethylhexyl)phthalate (DEPH), performed transcriptomic analysis of purified G1 and G2 prospermatogonia, found statistically significant overlap neither between upregulated genes in G1 and G2 nor between downregulated genes in the two prospermatogonia samples, and concluded that the EDCs do not cause TEI. My reanalysis of their data [2] using hypergeometric distribution probability showed that the overlap becomes highly significant if both up-and down-regulated genes are combined 
Data reanalysis
Szabó's [3] [3] shows the hypergeometric p values for significance of overlap between the combined set of up-and down-regulated genes in the first and the second generation, as does my Figure 1 [2] . A comparison of the data published in my Figure 1 [2] and that in Szabó's Table 1 found no evidence of methylation changes across generations. Moreover, should Szabó's speculation stand valid, would it not beg the question as to why overcompensation will be observed if there is no transgenerational effect? Regarding Szabó's objection [3] that adjustment for multiple hypothesis testing was not performed by me [2] , it is noted here that the significant p values shown in her Table 1 [3] as well as my Figure 1 [2] would all remain highly significant even after Bonferroni correction. For example, for the six hypotheses that have been tested in Table 1 , the nominal p values 1.16E-06, 4.04E-08, and 8.94E-04 become 6.96E-06, 2.42E-07, and 0.005, all significant, after adjustment. Cumulatively, Szabó's Table 1 Human genome was used in my analysis exactly to fulfill this requirement. Regarding Szabó's criticism that why did my Figure 2 , unlike one of my previous, unrelated papers, show significance values only for all the 36 studies combined, and not for each of these studies individually, it is noted here that the previous paper was related to miRNA counts wherein a zero "sample success" was not observed for any individual study, with the number of successes observed always being a positive number, mostly in tens or hundreds. In contrast, data related to Figure 2 frequently suffered from zero or very small sample success ( Table 1 ). Given that p value in general is dependent on sample size, significance of gene overlaps is a function of gene counts, and increased overlapping significance with growing gene counts is suggestive of the significance observed being a true signal [4] , my analysis reported p values for all the studies combined. The extent of overlap (fold enrichment) was nonetheless provided in the figure for individual studies. As regards adjustment for multiple testing, it was obvious from the figure that the nominal VZ-VZ overlapping significance shown (p = 0.0002) can easily survive an adjustment. Even when the p value shown is adjusted for 38 tests, representing 36 individual and 2 combined studies, using Bonferroni correction, the overlap remains significant (p = 0.007).
Regarding accompanying change in VZ-DEPH comparison, the change from significant nominal p (0.01) to insignificant adjusted p (0.38) is an expected one, as the two EDCs are expected to cause different gene expression effects at transcriptome level. Further, even when the probability of drawing the given number of successes at least, not exactly, is calculated, the VZ-VZ overlap shown in my figure remains significant. In this calculation, the nominal p value is obtained as 0.00057, and adjusted p as 0.021. Together, Szabó's Table 2 is found invalid, with my Figure 2 data supporting TEI remaining justified.
Prior evidence
Szabó argues that the evidence that I cited in support of the possibility that gene expression changes may show directional variability across generations in transgenerational epigenetic inheritance is inappropriate. Primarily, her concern is that a paper that I referred to showed directional change in gene expression between F1/F2 and F3, not between F1 and F2. She asserts that a lack of phenotype under investigation, primordial germ cell defects, in F3 renders this example unacceptable. Is not altered gene expression a phenotype in itself? Then, is not observing this molecular phenotype in F3 an evidence of TEI? Obviously, the answers to these questions are in the affirmative. Szabó's objection is hence not supported. Her next objection is that another paper that I cited relates to expression of miRNA, not mRNA, and to the worm C.
elegans, not mammals. How it is that miRNA expression change across generations is acceptable as evidence for TEI, whereas that of mRNA not? Also, is not C. elegans an established model of TEI? Moreover, as it is often difficult to cite all relevant papers in an article, the examples that I referred to were only illustrative, not exhaustive. The examples nonetheless conveyed the principal observation, that phenotypes, molecular or otherwise, can vary in directionality across generations in epigenetic inheritance. Given this, Szabó's assertion that there exists no support for directionality change in phenotypic expression in TEI does not hold. 
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Figure 1
Comparison of G1R-G2R gene overlap data. Whereas my analysis [2] presented the probability of drawing the given number of successes exactly, Szabó [3] calculated the probability of drawing the given number of successes at least. *indicates a note in the legend of my Figure 1 [2] clearly stating that the p value remains highly significant even when the probability is calculated for the given number of successes at least. 
